The other limitations included a lack of genomic and transcriptomic profiling data, a lack of sequential CD8+ and CD4+ T lymphocyte detection in peripheral blood, and a lack of biopsy specimens from metastatic lesions to detect the tumor microenvironment and lymphocyte infiltration. Here, CD8A is linked to neoplasm.